Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Transgenomic Inc.
DescriptionNext-generation sequencingtest for mutations in 448 genes formitochondrial disorders
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect mitochondrial disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today